Atlas Trials

Allena Pharmaceuticals

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Allena Pharmaceuticals

RecordFirmDate
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease (NCT04987294)Allena Pharmaceuticals2022-09-02
Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets (NCT05168683)Allena Pharmaceuticals2022-01-11
An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) (NCT04987242)Allena Pharmaceuticals2021-07-16
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) (NCT04829435)Allena Pharmaceuticals2021-04-21
ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers (NCT04236219)Allena Pharmaceuticals2020-09-02
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria (NCT03847090)Allena Pharmaceuticals2019-08-26
Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia (NCT03391804)Allena Pharmaceuticals2018-07-17
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria (NCT03456830)Allena Pharmaceuticals2018-05-21

Track Allena Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.